An X-linked lymphoproliferative syndrome (XLP) caused by mutations in the inhibitor-of-apoptosis gene XIAP;XIAP, un gène anti-apoptotique muté dans un nouveau syndrome lymphoprolifératif lié à l'X (XLP)

Medecine/Sciences

Volumn 23, Issue 3, 2007, Pages 235-237

  Rigaud, Stéphanie ^a   Latour, Sylvain ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 7; CASPASE 8; CASPASE 9; GAMMA INTERFERON; SERINE PROTEINASE OMI; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; X LINKED INHIBITOR OF APOPTOSIS;

CELL STRUCTURE; CHEMOTHERAPY; CLINICAL FEATURE; CYTOPLASM; ENZYME DEFICIENCY; EPSTEIN BARR VIRUS; GENE; GENE MUTATION; HOMEOSTASIS; HUMAN; HYPOGAMMAGLOBULINEMIA; IMMUNE RESPONSE; INFECTIOUS MONONUCLEOSIS; LYMPHOCYTE; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MITOCHONDRION; NOTE; SPLENOMEGALY;

EID: 33947518444     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2007233235     Document Type: Note

References (12)

1. Nichols KE, Ma CS, Cannons JL, et al. Molecular and cellular pathogenesis of X-linked lymphoproliferative disease. Immunol Rev 2005 ; 203 : 180-99.
2. De Saint Basile G, Fischer A. Defective cytotoxic granule-mediated cell death pathway impairs T lymphocyte homeostasis. Curr Opin Rheumatol 2003 ; 15 : 436-45.
3. Latour S, Gish G, Helgason CD, et al. Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product. Nat Immunol 2001 ; 2 : 681-90.
4. Rigaud S, Fondaneche MC, Lambert N, et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 2006 ; 444 : 110-4.
5. + T cells against EBV-infected cells. Blood 2005 ; 105 : 4383-9.
6. Parolini S, Bottino C, Falco M, et al. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J Exp Med 2000 ; 192 : 337-46.
7. Bottino C, Falco M, Parolini S, et al. NTB-A (correction of GNTB-A), a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. J Exp Med 2001 ; 194 : 235-46.
8. Pasquier B, Yin L, Fondaneche MC, et al. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J Exp Med 2005 ; 201 : 695-701.
9. Nichols KE, Hom J, Gong Sy, et al. Regulation of NKT cell development by SAP, the protein defective in XLP. Nat Med 2005 ; 11 : 340-5.
10. Salvesen GS, Duckett CS. IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 2002 ; 3 : 401-10.
11. Rieux-Laucat F. Autoimmune lymphoproliferative syndrome: an inherited or a somatic defect of apoptosis. Med Sci (Paris) 2006 ; 22 : 645-9.
12. Lin Y, Roberts TJ, Wang CR, et al. Long-term loss of canonical NKT cells following an acute virus infection. Eur J Immunol 2005 ; 35 : 879-89.